For the quarter ending 2026-03-31.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|
| General and administrative costs | 387,273 | 508,225 | 135,337 | |
| Loss from operations | -387,273 | -508,225* | -135,337 | |
| Advisory fee expense | - | -3,289,000* | 1,644,500 | |
| Advisory fee - reimbursable income | - | -880,000* | 440,000 | |
| Interest earned on marketable securities held in trust account | 2,103,365 | -882,551* | 1,727,160 | |
| Interest earned on cash equivalents | 8,511 | 3,675* | 3,041 | |
| Total other income | 2,111,876 | 1,530,124* | 525,701 | |
| Net income | 1,724,603 | 1,021,899 | 390,364 | |
| Basic EPS | 0.05 | 0.077 | 0.02 | |
| Diluted EPS | 0.05 | 0.077 | 0.02 | |
| Basic Average Shares | 25,300,000 | 13,322,692 | 15,675,000 | |
| Diluted Average Shares | 25,300,000 | 13,322,692 | 15,675,000 | |
HCM III ACQUISITION CORP. (HCMAW)
HCM III ACQUISITION CORP. (HCMAW)